DIN 02522470 — MAVIRET 20 MG; 50 MG
MAVIRET is a granules of Glecaprevir / Pibrentasvir marketed by ABBVIE CORPORATION. The full Glecaprevir / Pibrentasvir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02522470
- Brand name
- MAVIRET
- Active ingredient
- Glecaprevir / Pibrentasvir
- Strength
- 20 MG; 50 MG
- Dosage form
- GRANULES
- Route
- ORAL
- Manufacturer
- ABBVIE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Direct-acting antiviral combination (NS3/4A protease inhibitor + NS5A inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Glecaprevir / Pibrentasvir products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02467550 | MAVIRET | 40 MG; 100 MG | TABLET | ABBVIE CORPORATION | MARKETED |